Aurobindo Pharma shines on plan to invest around Rs 1,300 crore towards capex

18 Nov 2014 Evaluate
Aurobindo Pharma is currently trading at Rs. 1141.20, up by 33.85 points or 3.06% from its previous closing of Rs. 1107.35 on the BSE.

The scrip opened at Rs. 1116.35 and has touched a high and low of Rs. 1147.25 and Rs. 1113.00 respectively. So far 56749 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1147.25 on 18-Nov-2014 and a 52 week low of Rs. 271.15 on 21-Nov-2013.

Last one week high and low of the scrip stood at Rs. 1147.25 and Rs. 1021.50 respectively. The current market cap of the company is Rs. 33192.00 crore.

The promoters holding in the company stood at 54.10% while Institutions and Non-Institutions held 35.67% and 10.22% respectively.

Aurobindo Pharma is planning to invest around Rs 1,300 crore towards capex during the ongoing and next financial years. The capex will be spread out across APIs (active pharmaceutical ingredients) and formulations and the company’s operations have resulted in substantial improvement to support the capex through internal cash generation.

Moreover, the pharma company spent around Rs 275 crore during the first half the current year. Meanwhile, consolidated net operating income of Aurobindo in second quarter of the ongoing fiscal grew 50 per cent to Rs 2,881 crore over the same period a year ago. Profit After Tax (after minority interest) was up by 58.4 per cent to Rs 372.2 crore during the July-September quarter against Rs 235 crore in the same quarter last fiscal. 

Aurobindo Pharma Share Price

1217.45 -6.20 (-0.51%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×